Results 51 to 60 of about 42,161,849 (355)

Pathways and pitfalls: a qualitative study of student experiences in biomedical science education

open access: yesFEBS Open Bio, EarlyView.
Biomedical science students from underrepresented backgrounds face barriers including financial strain, disrupted laboratory access and cultural exclusion. Peer networks provide vital support when institutional systems are difficult to navigate. To create inclusive learning environments and achieve academic success, educators should blend active, hands‐
Olivia J. Russell   +8 more
wiley   +1 more source

Innate Immune Reprogramming Mediated by Endogenous Retroelement Dysregulation Drives Multiple Sclerosis Progression

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao   +6 more
wiley   +1 more source

E-marketing

open access: yes, 2009
Sadržajno gledano, u odnosu na prethodna izdanja u ovoj knjizi riječ je samo manjim dijelom o inoviranju i proširenju dijelova teksta, a većim dijelom radi se o potpuno novom rukopisu. Ova je knjiga, kao i prethodne, nastala iz potrebe za pokrivanjem novog područja primjene marketinga.
Turkalj, Davorin   +2 more
openaire   +1 more source

Artificial intelligence and marketing innovation: The mediating role of organizational culture

open access: yesInnovative Marketing
The rapid advancement of artificial intelligence (AI) is transforming the e-commerce landscape, prompting businesses to adopt innovative marketing strategies.
Abdelrehim Awad
semanticscholar   +1 more source

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock   +4 more
wiley   +1 more source

O marketing esportivo: diferenças e semelhanças entre futebol e voleibol [PDF]

open access: yes, 2012
TCC (Graduação) - Universidade Federal de Santa Catarina. Centro de Desportos. Curso de Graduação em Educação Física.Os clubes brasileiros começaram a olhar o marketing esportivo com outros olhos no inicio do século XX, principalmente no futebol para ...
Mendes, Felipe Goedert
core  

“Start-up Marketing”, ecosistemi innovativi e “market infrastructure”: una prospettiva practice-based

open access: yes, 2021
Questo lavoro propone un “situated-sociocultural approach to language, literacy and technology” per indagare l’emergere dello “start-up marketing” e del marketing negli “ecosistemi innovativi”.
Crisci F., Cagnina M. R.
core  

Uma história que permanece viva

open access: yesRevista Alterjor, 2014
O jornalismo e o ensino do jornalismo cumprem seu papel quando ajudam a contar e a recontar a história, resgatando, em documentos ou por meio da fala de cidadãos, a memória de um povo.
Enio Moraes Jr   +4 more
doaj  

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy